The IDSA Center for Global Health Policy and the HIV Medicine Association released a policy statement on the results of HPTN 052 with recommendations for U.S. global and domestic AIDS Policy. Entitled “U.S. Policy and Funding on AIDS Should Follow the Science,” the statement recommends that a larger share of the PEPFAR budget be devoted […]
The following is a blog post by Kristen Jill Kresge of the International AIDS Vaccine Initiative. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Kresge provides a synopsis of the first plenary session of the conference. The post was originally published on IAVIReport. At the first plenary session of AIDS Vaccine 2011, which opened this […]
The following is a blog post by Jose Esparza, Deputy Director of HIV Vaccines at the Bill and Melinda Gates Foundation. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Dr. Esparza discusses recent scientific developments in the creation of an AIDS vaccine, and what we can expect to see in the future. The post […]
HIV
Once outbreak was recognized, program put in place reduced number of ongoing transmissions, modeling shows In 2015, when 181 of rural Scott County, Indiana’s 24,000 residents […]
Tuberculosis
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
GENEVA – The countries least responsible for climate change are paying the highest price in health impacts, a delegate from Barbados was the first to note […]